Research and Markets: Prexton Therapeutics SA - Product Pipeline Review - Analysis, Technologies & Forecasts 2015

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/l6939x/prexton) has announced the addition of the "Prexton Therapeutics SA - Product Pipeline Review - 2015" company profile to their offering.

This report provides comprehensive information on the current therapeutic developmental pipeline of Prexton Therapeutics SA's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Key Topics Covered:

  • The report provides brief overview of Prexton Therapeutics SA including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Prexton Therapeutics SA's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Prexton Therapeutics SA's pipeline products

Benefits of this Report:

  • Evaluate Prexton Therapeutics SA's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Prexton Therapeutics SA in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Prexton Therapeutics SA's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Prexton Therapeutics SA and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Prexton Therapeutics SA
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Prexton Therapeutics SA and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

For more information visit http://www.researchandmarkets.com/research/l6939x/prexton

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals